Recently, the Breast Laparoscopic Surgery Training Course of the China Laparoscopic Breast Surgery Alliance and the Breast Branch Election Conference of the Hunan Traditional Chinese Medicine Information Research Association concluded successfully in Changsha.
At the meeting, Nanhua Hospital affiliated to the University of Nanhua was rated as the leading unit for breast endoscopic technology (Southern Hunan region), and Lu Pengfei, director of the Department of Acupuncture and Breast Surgery, was elected as the deputy director of the Breast Branch. This double happiness has opened a new chapter for the development of breast surgery in the hospital and even the entire Shonan region.
The election of Director Lu Pengfei is a high recognition of his long-term unremitting exploration and outstanding contributions in the field of breast surgery.
With his profound medical insight, superb surgical skills and in-depth research on breast endoscopic technology, he not only set a technical benchmark in the breast surgery community in southern Hunan, but also brought more precise and minimally invasive treatments to the majority of patients. choice, significantly improving treatment effects and patient satisfaction.
Under the leadership of Director Lu Pengfei, the breast surgery team of Nanhua Hospital continues to innovate and have the courage to make breakthroughs. It not only pursues the ultimate in technology, but also makes comprehensive progress in discipline construction, scientific research and teaching. He formulated a scientific and forward-looking strategic plan for the development of breast endoscopic technology in the hospital, and successfully promoted the leading position in this field in the Shonan region.
Faced with the new honor and mission, Director Lu Pengfei said that this is not only an affirmation of past achievements, but also a spur for future work. He will continue to uphold his original intention and devote himself to the development and innovation in the field of breast surgery with fuller enthusiasm and firm belief.
At the same time, as the deputy chairman of the Breast Branch, he will also actively play the role of bridge and link, lead the department to fulfill the responsibilities of the leading unit in southern Hunan, promote academic exchanges and cooperation, and jointly promote the prosperity and development of breast surgery.
Expert introduction
Lu Pengfei, director of the Department of Atomy and Breast Surgery, Nanhua Hospital Affiliated to the University of Nanhua, doctor of oncology, master's tutor, deputy chief physician, scholar studying in the United States
Academic position: 2
Chairman of China Cross-Strait Endoscopic Surgery Exchange Association; China Breast Cancer Head of the leading unit of the Minimally Invasive and Laparoscopy Alliance in southern Hunan; Member of the Chinese Anti-Cancer Association Thyroid Cancer Professional Committee; Member of the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association; Member of the Chinese Medical Education Association Head and Neck Tumor Professional Committee; China Transformation Member of the Medical Committee; member of the Head and Neck Tumor Professional Committee of the Tianjin Anti-Cancer Association; member of the Standing Committee of the Breast Cancer Professional Committee of the Traditional Chinese Medicine Information Research Association, etc.
participated in 2 national projects, presided over 2 provincial natural projects, presided over 2 department-level projects, presided over 1 school-level project, 2 invention patents, and wrote 3 monographs. Won the third prize of the Provincial Natural Science Award and the honorary title of “Public Welfare Pioneer” by the Red Cross Society of China.
has published 41 papers, with a cumulative sci impact factor of nearly 70. He serves as an editorial board member of the European Journal of Gynaecological Oncology; an editor and reviewer of many SCI journals such as International Journal of Surgery, Frontiers in Oncology, Aging, Clinical and Transnational Oncology.
Professional expertise:
is proficient in the standardized diagnosis, treatment and full-process management of thyroid and breast diseases. He is good at difficult surgery of breast and thyroid tumors and minimally invasive endoscopic surgery, ultrasonic and radiofrequency ablation, and has carried out many new technologies and projects, such as Immediate and delayed breast reconstruction for breast cancer, breast-conserving surgery, breast reconstruction (fat, implant, latissimus dorsi muscle and abdominal skin flap (diep)), breast augmentation with implants, large breast reduction, breast lift, nipple plastic surgery after breast-conserving surgery; The "single-port four-instrument" nsm + stage I breast muscle anterior (posterior) prosthesis reconstruction surgery of the axilla under invasive mammography has overcome the dual-plane breast technology under laparoscopy (replacing the film).
is particularly good at minimally invasive endoscopic thyroid surgery through transoral, transaxillary, transthoracic and other approaches; transoral endoscopic radical thyroidectomy and lateral neck lymph node dissection have reached the domestic leading level, and there is no scar on the body surface; feasible Da Vinci robot xi/single-hole sp surgery; won the "Removal of Armor - Recommended by China's Outstanding Thyroid Surgeons", and is invited for surgical consultations inside and outside the province all year round.
has studied in many well-known tumor centers at home and abroad, such as Buffett Cancer Hospital in the United States, Tianjin Cancer Hospital, the First Affiliated Hospital of University of Science and Technology of China, and Hunan Provincial Cancer Hospital. Recently, the Breast Laparoscopic Surgery Training Course of the China Laparoscopic Breast Surgery Alliance and the Breast Branch Election Conference of the Hunan Traditional Chinese Medicine Information Research Association concluded successfully in Changsha. At the meeting, Nanhua Hospital affiliated to the University of Nanhua was rated as the leading unit for breast endoscopic technology (Southern Hunan region), and Lu Pengfei, director of the Department of Acupuncture and Breast Surgery, was elected as the deputy director of the Breast Branch. This double happiness has opened a new chapter for the development of breast surgery in the hospital and even the entire Shonan region. The election of Director Lu Pengfei is a high recognition of his long-term unremitting exploration and outstanding contributions in the field of breast surgery. With his profound medical insight, superb surgical skills and in-depth research on breast endoscopic technology, he not only set a technical benchmark in the breast surgery community in southern Hunan, but also brought more precise and minimally invasive treatments to the majority of patients. choice, significantly improving treatment effects and patient satisfaction. Under the leadership of Director Lu Pengfei, the breast surgery team of Nanhua Hospital continues to innovate and have the courage to make breakthroughs. It not only pursues the ultimate in technology, but also makes comprehensive progress in discipline construction, scientific research and teaching. He formulated a scientific and forward-looking strategic plan for the development of breast endoscopic technology in the hospital, and successfully promoted the leading position in this field in the Shonan region. Faced with the new honor and mission, Director Lu Pengfei said that this is not only an affirmation of past achievements, but also a spur for future work. He will continue to uphold his original intention and devote himself to the development and innovation in the field of breast surgery with fuller enthusiasm and firm belief. At the same time, as the deputy chairman of the Breast Branch, he will also actively play the role of bridge and link, lead the department to fulfill the responsibilities of the leading unit in southern Hunan, promote academic exchanges and cooperation, and jointly promote the prosperity and development of breast surgery. Expert introduction Lu Pengfei, director of the Department of Atomy and Breast Surgery, Nanhua Hospital Affiliated to the University of Nanhua, doctor of oncology, master's tutor, deputy chief physician, scholar studying in the United States Academic position: 2 Chairman of China Cross-Strait Endoscopic Surgery Exchange Association; China Breast Cancer Head of the leading unit of the Minimally Invasive and Laparoscopy Alliance in southern Hunan; Member of the Chinese Anti-Cancer Association Thyroid Cancer Professional Committee; Member of the Breast Cancer Professional Committee of the Chinese Anti-Cancer Association; Member of the Chinese Medical Education Association Head and Neck Tumor Professional Committee; China Transformation Member of the Medical Committee; member of the Head and Neck Tumor Professional Committee of the Tianjin Anti-Cancer Association; member of the Standing Committee of the Breast Cancer Professional Committee of the Traditional Chinese Medicine Information Research Association, etc. participated in 2 national projects, presided over 2 provincial natural projects, presided over 2 department-level projects, presided over 1 school-level project, 2 invention patents, and wrote 3 monographs. Won the third prize of the Provincial Natural Science Award and the honorary title of “Public Welfare Pioneer” by the Red Cross Society of China. has published 41 papers, with a cumulative sci impact factor of nearly 70. He serves as an editorial board member of the European Journal of Gynaecological Oncology; an editor and reviewer of many SCI journals such as International Journal of Surgery, Frontiers in Oncology, Aging, Clinical and Transnational Oncology. Professional expertise: is proficient in the standardized diagnosis, treatment and full-process management of thyroid and breast diseases. He is good at difficult surgery of breast and thyroid tumors and minimally invasive endoscopic surgery, ultrasonic and radiofrequency ablation, and has carried out many new technologies and projects, such as Immediate and delayed breast reconstruction for breast cancer, breast-conserving surgery, breast reconstruction (fat, implant, latissimus dorsi muscle and abdominal skin flap (diep)), breast augmentation with implants, large breast reduction, breast lift, nipple plastic surgery after breast-conserving surgery; The "single-port four-instrument" nsm + stage I breast muscle anterior (posterior) prosthesis reconstruction surgery of the axilla under invasive mammography has overcome the dual-plane breast technology under laparoscopy (replacing the film). is particularly good at minimally invasive endoscopic thyroid surgery through transoral, transaxillary, transthoracic and other approaches; transoral endoscopic radical thyroidectomy and lateral neck lymph node dissection have reached the domestic leading level, and there is no scar on the body surface; feasible Da Vinci robot xi/single-hole sp surgery; won the "Removal of Armor - Recommended by China's Outstanding Thyroid Surgeons", and is invited for surgical consultations inside and outside the province all year round. has studied in many well-known tumor centers at home and abroad, such as Buffett Cancer Hospital in the United States, Tianjin Cancer Hospital, the First Affiliated Hospital of University of Science and Technology of China, and Hunan Provincial Cancer Hospital. Hunan Medical Chat special authors: Jiang Yunxia, Chen Ranxi, Nanhua Hospital Affiliated to the University of South China Follow @Hunan Medical Chat to get more health science information! (edited by yt)